Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07158177
NA

Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Retrospective, comparative, interventional, randomized, single-center study, contralateral (the patient's 2 eyes will be implanted: 1 CPO and the other APO) Patients presenting for cataract surgery with a request for presbyopia correction and managed as part of routine clinical practice. The main aim of the study is to demonstrate that contrast sensitivity is better with the Clareon PanOptix (CPO) intraocular lens (IOL) compared with the AcrySof PanOptix (APO) IOL 3 months after implantation.

Official title: Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity. Study of Two Different Material of Intra Ocular Multifocal Lenses Aiming to Compare the Effect on Contrast Sensitivity.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-10-01

Completion Date

2026-10-15

Last Updated

2026-03-30

Healthy Volunteers

No

Interventions

DEVICE

Acrysof™ PanOptix™ toric or not, trifocal IOL CE marked, Alcon company.

both of the patient's eyes will be implanted: 1 CPO and the other APO

DEVICE

Clareon Panoptix

both of the patient's eyes will be implanted: 1 CPO and the other APO

Locations (1)

Assistance Publique - Hôpitaux de Paris, Ophtalomopôle - Hôpital COCHIN

Paris, Île-de-France Region, France